Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. News
  7. All News
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
  Report
Delayed Swiss Exchange  -  11:30 2022-07-04 am EDT
0.1085 CHF   -1.36%
06/26IGEA PHARMA N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
06/15IGEA PHARMA N : Note of the Board
PU
06/15IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about IGEA PHARMA N.V.
06/26IGEA PHARMA N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
06/15IGEA PHARMA N : Note of the Board
PU
06/15IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
06/08Igea Pharma Secures $6 Million Funds To Complete Cannabidiol Extraction Facility
MT
06/07IGEA PHARMA N.V. : Igea pharma has signed a preliminary agreement with lmh-an industrial h..
EQ
05/02IGEA Pharma Gets Swiss Bourse Approval To Delay FY21 Annual Report Publication
MT
05/02IGEA PHARMA N.V. : IGEA to get SIX approval to delay the 2021 annual report disclosure
EQ
05/01IGEA PHARMA N : to get SIX approval to delay the 2021 annual report disclosure
PU
02/01IGEA PHARMA N : non-executive board members resigned after completion of the first post-co..
PU
2021IGEA PHARMA N : GBC Research report IGEA Pharma N.V.
PU
2021IGEA PHARMA N : GBC AG Publishes initial equity research report with buy recommendation an..
PU
2021IGEA PHARMA N.V. : Gbc ag publishes initial equity research report with buy recommendation..
EQ
2021IGEA PHARMA N : GBC AG to start equity coverage of IGEA Pharma
PU
2021IGEA PHARMA N : H1 Loss Narrows on Gains From Financial Liabilities, Sale of Assets
MT
2021IGEA Pharma N.V. Reports Earnings Results for First Half 2021
CI
2021Igea Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021IGEA PHARMA N : discloses its half-2021 financials
PU
2021IGEA PHARMA N : has been granted the listing of the new shares from SIX Exchange Regulatio..
PU
2021IGEA PHARMA N : to submit the listing prospectus to the SIX following the business combina..
PU
2021IGEA PHARMA N : to boost revenues entering the growing cannabis market
PU
2021IGEA PHARMA N : Expects Earnings, Revenue Boost On Blue Sky Natural Resources Deal
MT
2021IGEA PHARMA N : Declares All-Equity Offer for Blue Sky Natural Resources Unconditional
MT
2021IGEA PHARMA N : Minutes of the AGM 9 July 2021 + Attendance list
PU
2021IGEA PHARMA N : announces Annual General Meeting resolutions
PU
2021IGEA PHARMA N : Launches All-Equity Offer To Buy Blue Sky Natural Resources
MT
2021IGEA PHARMA N : To launch the all equity offer to blue sky natural resources ltd.
EQ
2021IGEA PHARMA N : Convening notice and agenda
PU
2021IGEA PHARMA N : Names New Chair
MT
2021IGEA PHARMA N : announces changes in its board and other corporate updates
EQ
2021IGEA Pharma N.V. Announces Executive Changes
CI
2021IGEA PHARMA N : announces changes in its board and other corporate updates
PU
2021IGEA PHARMA N : disclosed its Annual Report 2020
EQ
2021IGEA PHARMA : Annual report
PU
2021IGEA PHARMA N : disclosed its Annual Report 2020
PU
2021IGEA PHARMA N : Secures $12 Million Investment From Negma
MT
2021IGEA Pharma N.V. Reports Unaudited Earnings Results for the Year 2020
CI
2021IGEA PHARMA N : to get SIX approval to delay the 2020 annual report disclosure
EQ
2021IGEA PHARMA N : to get SIX approval to delay the 2020 annual report disclosure
PU
2021IGEA PHARMA N : announces extraordinary general meeting results
EQ
2021IGEA PHARMA N : announces extraordinary general meeting results
PU
2021IGEA PHARMA N : Minutes of the EGM 28 April 2021
PU
2021IGEA Pharma Strikes Two-Year Convertible Bond Deal With Negma
MT
2021IGEA PHARMA N : to secure convertible bond commitment with Negma Group
PU
2021IGEA PHARMA N : to secure convertible bond commitment with Negma Group
EQ
2021IGEA PHARMA N : CFO Resigns, Interim Successor Appointed
MT
2021IGEA Pharma N.V. Announces Termination of Patrick Pozzorini as CFO
CI
2021IGEA PHARMA N : and its CFO end collaboration
EQ
2021IGEA PHARMA N : and its CFO end collaboration
PU
2021IGEA PHARMA N : Convening notice
PU
2021IGEA PHARMA N : to finalize on convertible bond facility arrangement
PU
2021IGEA Pharma N.V. announced that it expects to receive €10 million in funding from Negma..
CI
2021IGEA PHARMA N : calls extraordinary general meeting
PU
2021IGEA PHARMA N : announces three new board members
EQ
2021IGEA PHARMA N : announces three new board members
PU
2021IGEA Pharma N.V. Announces Three New Board Members
CI
2021IGEA PHARMA N : calls extraordinary general meeting
EQ
2021IGEA PHARMA N : announces changes in its board
PU
2021IGEA PHARMA N : announces changes in its board
EQ
2021IGEA Pharma N.V. Announces Resignation of Mr. Camillo Ricordi and Mr. Barth Armand Gree..
CI
2021IGEA PHARMA N : to Close Blue Sky Natural Resources Merger in April
MT
2021IGEA PHARMA N : to update on business combination
EQ
2020IGEA Pharma N.V. Announces Signature of an Agreement with CSM Europe for the CE Complia..
CI
2020IGEA PHARMA N : ensures ‘Alz1' supply for the EU market
PU
2020IGEA Pharma N.V. cancelled the acquisition of 66% stake in Meditalia Srl from from cert..
CI
2020IGEA PHARMA N : announces changes in its board
EQ
2020IGEA Pharma N.V. Announces Resignation of Mark De Simone from the Board of Directors
CI
2020IGEA PHARMA N : discloses its half-2020 financials
EQ
2020IGEA Pharma N.V. Reports Group Earnings Results for the First Half Ended June 30, 2020
CI
2020IGEA PHARMA N : discloses its half-2020 financials
PU
2020Blue Sky Natural Resources Ltd signed letter of intent to acquire IGEA Pharma N.V. in a..
CI
2020IGEA PHARMA N : and Blue Sky Natural Resources to combine businesses
EQ
2020IGEA PHARMA N : announces changes in its board
EQ
2020IGEA Pharma N.V. Announces the Resignation of Marco Seniga from its Board of Directors
CI
2020IGEA PHARMA N : announces changes in its board
PU
2020IGEA PHARMA N : announces annual general meeting resolutions
PU
1  2Next
Upcoming sector events
07/29/22DIASORIN S.P.A. : Interim 2022 Earnings Release
08/03/2210X GENOMICS, INC. : Interim 2022 Earnings Release (Projected)
08/05/22AUTOBIO DIAGNOSTICS CO., LTD. : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Medical Equipment, Supplies & Distribution
   Diagnostic & Testing Substances